FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
RBC Capital analyst Brian Abrahams lowered the price target on Incyte (NASDAQ: INCY) to $87.00 (from $90.00) while maintaining an Outperform rating and said they would buy on weakness.
The analyst commented, "4Q featured strong initial launch metrics for Opzelura, solid sales for INCY's core MF... More


